Advertisement
UK markets open in 5 hours 55 minutes

  • NIKKEI 225

    37,771.61
    -190.19 (-0.50%)
     

  • HANG SENG

    16,251.84
    +2.87 (+0.02%)
     

  • CRUDE OIL

    82.69
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,383.40
    -5.00 (-0.21%)
     

  • DOW

    37,753.31
    -45.66 (-0.12%)
     

  • Bitcoin GBP

    49,433.27
    -1,964.00 (-3.82%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • NASDAQ Composite

    15,683.37
    -181.88 (-1.15%)
     

  • UK FTSE All Share

    4,273.02
    +12.61 (+0.30%)
     
Money:

5 ways to get help with childcare costs

Childcare is eye-wateringly expensive, here are some ways to save money

Samsung Bioepis hires banks for planned Nasdaq IPO -source

Reuters

SEOUL (Reuters) - South Korea's Samsung Bioepis Co Ltd, a biosimilar drug development arm of conglomerate Samsung Group, has hired four banks to manage its planned U.S. listing next year, a person with direct knowledge of the matter said on Thursday.

Samsung Bioepis hired Citigroup and Goldman Sachs as the lead managers for the Nasdaq listing, the person told Reuters, with Credit Suisse and Morgan Stanley also taking part in the deal.

The person declined to elaborate further, including how much Samsung Bioepis might raise through the listing. Bioepis has said it plans to complete the IPO process by end-June 2016.

(Reporting by Se Young Lee; Editing by Miral Fahmy)